Ian Chau, David Cunningham. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adenomatous Polyposis Coli/geneticsAdenomatous Polyposis Coli/prevention & controlAdenomatous Polyps/prevention & controlAnti-Inflammatory Agents, Non-Steroidal/therapeutic useCelecoxibColonic Polyps/prevention & controlCyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase Inhibitors/therapeutic useGenes, APCGerm-Line MutationHumansIsoenzymes/antagonists & inhibitorsMembrane ProteinsProstaglandin-Endoperoxide SynthasesPyrazolesSulfonamides/therapeutic useSulindac/therapeutic use
Substances： See more » Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIsoenzymesMembrane ProteinsPyrazolesSulfonamidesSulindacCyclooxygenase 2PTGS2 protein, humanProstaglandin-Endoperoxide SynthasesCelecoxib
Year: 2002 PMID： 11932478 DOI： 10.1056/NEJM200204043461412
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245